Show items per page
Elements: 53
Page 1 on 3
 TitleAuthors / EditorsDate
add to browser selection
Zidovudine plus didanosine in primary HIV-1 infection Perrin, Luc; Yerly Ferrillo, Sabine; Charvier, A.; Figueras, G.; ... Hirschel, Bernard 1997
add to browser selection
Viral suppression rates in salvage treatment with raltegravir improved with the administration of genotypic partially active or inactive nucleoside/tide reverse transcriptase inhibitors Scherrer, Alexandra U; von Wyl, Viktor; Böni, Jürg; Yerly Ferrillo, Sabine; ... Günthard, Huldrych F 2011
add to browser selection
Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study Gonvers, Jean-Jacques; Heim, Markus H.; Cavassini, Matthias; Mullhaupt, Beat; ... Oneta, Carl 2010
add to browser selection
The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients Fattovich, Giovanna; Covolo, Loredana; Pasino, Michela; Perini, Eleonora; ... Donato, Francesco 2011
add to browser selection
Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV Cohort Hirschel, Bernard; Flepp, Markus; Bucher, H. C.; Zellweger, Claudine; ... Ledergerber, Bruno 2002
add to browser selection
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection Fätkenheuer, Gerd; Nelson, Mark; Lazzarin, Adriano; Konourina, Irina; ... van der Ryst, Elna 2008
add to browser selection
Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients Calmy, Alexandra; Bel, Michael; Nguyen, A; Combescure, Christophe; ... Villard, Jean 2012
add to browser selection
Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study Khanna, Nina; Klimkait, T.; Schiffer, V.; Irigoyen, J.; ... Battegay, M. 2000
add to browser selection
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study Bucher, H. C.; Bichsel, M.; Taffe, Patrick; Furrer, Hansjakob; ... Battegay, M. 2002
add to browser selection
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial El-Sadr, W. M.; Grund, B.; Neuhaus, J.; Babiker, A.; ... Neaton, J. D. 2008
add to browser selection
Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation Giostra, Emiliano; Kullak-Ublick, Gerd A; Keller, Walter; Fried, Ronald; ... Negro, Francesco 2004
add to browser selection
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study Friedl, A. C.; Ledergerber, Bruno; Flepp, Markus; Hirschel, Bernard; ... Weber, R. 2001
add to browser selection
Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load Oxenius, Annette; Price, D. A.; Dawson, S. J.; Gunthard, Huldrych; ... Phillips, R. E. 2002
add to browser selection
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission Elzi, Luigia; Schlegel, Matthias; Weber, Rainer; Hirschel, Bernard; ... Furrer, Hansjakob 2007
add to browser selection
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study Assoumou, Lambert; Descamps, Diane; Yerly Ferrillo, Sabine; Dos Santos, Georges; ... Masquelier, Bernard 2013
add to browser selection
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study Wolbers, Marcel; Opravil, Milos; von Wyl, Viktor; Hirschel, Bernard; ... Bucher, H. C. 2007
add to browser selection
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era Boffi El Amari, Emmanuelle; Toutous-Trellu, Laurence; Gayet-Ageron, Angèle; Baumann, Michele; ... Hirschel, Bernard 2008
add to browser selection
Outcomes of patients on dual-boosted PI regimens: experience of the Swiss HIV cohort study Osih, Regina B.; Taffe, Patrick; Rickenbach, Martin; Gayet-Ageron, Angèle; ... Cavassini, Matthias 2010
add to browser selection
Mobilization of peripheral blood progenitor cells for human immunodeficiency virus-infected individuals Law, P; Lane, T A; Gervaix, Alain; Looney, D; ... Ho, A D 1999
add to browser selection
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients Scherrer, Alexandra U; Ledergerber, Bruno; von Wyl, Viktor; Böni, Jürg; ... Günthard, Huldrych F 2012
<< previous | 1 | 2 | 3 |